Cargando…
Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells
Novel therapies to override chemo-radiation resistance in prostate cancer (PCa) are needed. Prostate cancer sphere-forming cells (PCSCs) (also termed prostate cancer stem-like cells) likely participate in tumor progression and recurrence, and they are important therapeutic targets. We established PC...
Autores principales: | Wang, Lei, Ning, Jianfang, Wakimoto, Hiroaki, Wu, Shulin, Wu, Chin-lee, Humphrey, Melissa R., Rabkin, Samuel D., Martuza, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468160/ https://www.ncbi.nlm.nih.gov/pubmed/31016228 http://dx.doi.org/10.1016/j.omto.2019.03.008 |
Ejemplares similares
-
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma
por: Kawamura, Yoichiro, et al.
Publicado: (2022) -
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
por: Ning, Jianfang, et al.
Publicado: (2014) -
Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models
por: Passer, Brent J., et al.
Publicado: (2012) -
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
por: Peng, Xin, et al.
Publicado: (2021) -
Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
por: Peng, Xin, et al.
Publicado: (2021)